Fiona Wood AO (b.1958), plastic and reconstructive surgeon, is co-founder of the biotech company Clinical Cell Culture Limited (known as C3), which pioneers and commercialises treatments for burns. Yorkshire-born Wood studied medicine in London before migrating to Perth, Western Australia in 1987 and completing her training in plastic surgery there. From 1993 she worked on the development of CellSpray, a process aimed at speeding the regrowth of skin tissue over burns. Woods founded C3 in 2000 in partnership with medical scientist Marie Stoner and the company was listed on the Stock Exchange in 2002; CellSpray was launched in Europe in 2005.
Although she had long been recognised as a leader in the field of burns treatment, Wood came to national prominence in 2002, when 28 victims of the Bali bombings were flown to Perth for care. Named a Living National Treasure in 2004 and Australian of the Year in 2005, she continues to specialise in major burn care, trauma and scar reconstruction in her roles as Director of the Burns Service of WA (BSWA), Consultant Plastic Surgeon at Fiona Stanley Hospital and Princess Margaret Hospital for Children and Winthrop Professor (Burns Injury Research Unit) at the University of Western Australia. She is also co-founder of the Fiona Wood Foundation (formerly the McComb Foundation), which supports ongoing burns research with the aim of achieving ‘scarless, woundless healing’.